Praxis Precision Medicines Inc. (PRAX) PT Raised to $550 at Jefferies

May 7, 2026 1:54 PM

Jefferies analyst Andrew Tsai raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $550.00 (from $525.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found